To verify whether the inhibition effects of tRF-T36 mimic on CRC cells were mediated by PI3K/Akt, a rescue experiment was carried out with the employment of 740Y-P which is an agonist of PI3K-Akt pathway [29]. This evidence concerns the gene AKT1 and colorectal carcinoma.